Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 9:13:7.
doi: 10.1186/1476-0711-13-7.

Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients

Aziz Ogutlu  1 , Ertugrul Guclu, Oguz Karabay, Aylin Calica Utku, Nazan Tuna, Mehmet Yahyaoglu
Affiliations

Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients

Aziz Ogutlu et al. Ann Clin Microbiol Antimicrob. .

Abstract

Background: The consumption of carbapenems has increased worldwide, together with the increase in resistant gram negative bacilli. Subsequently, the prevalence of carbapenem-resistant Acinetobacter infections has increased rapidly and become a significant problem particularly in intensive care unit patients. The aim of the present study was to evaluate the changes in the prevalence of Acinetobacter infection by restricting the consumption of carbapenems in intensive care unit patients.

Methods: This study was conducted between May 1, 2011 and February 28, 2013. The amount of carbapenem consumption and the number of patients with multi-drug resistant Acinetobacter baumannii (MDRAB) isolates during the study period were retrospectively obtained from the records of the patients, who were hospitalized in the intensive care unit. The study period was divided into two periods named as: Carbapenem non-restricted period (CNRP) and carbapenem-restricted period (CRP). During CNRP, no restrictions were made on the use of carbapenems. During CRP, the use of carbapenems was not allowed if there was an alternative to carbapenems. Primary Endpoint: MDRAB infection after ICU admission. The definition of nosocomial infections related to Acinetobacter spp. was based on the criteria of the Center for Disease Control (CDC). The correlation between the amount of carbapenem consumption and the number of infections with MDRAB strains between the two periods were evaluated.

Results: During the study period, a total of 1822 patients' (1053 patients in CNRP and 769 patients in CRP) records were evaluated retrospectively. A total of 10.82 defined daily dose (DDD/100 ICU days) of anti-pseudomonal carbapenem were used in CNRP, and this figure decreased to 6.95 DDD/100 ICU days in CRP. In the 8-month CNRP, 42 (3.98%) MDRAB-related nosocomial infections were detected, and 14 (1.82%) infections were detected in CRP (p = 0.012).

Conclusion: The prevalence of MDRAB strains isolated in the CNRP was 2.24-fold higher than the prevalence in the CRP. The prevalence of Acinetobacter infections can be reduced by taking strict isolation measures as well as by implementing good antibiotics usage policy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distrubition of the isolated microorganisms in the study periods.
Figure 2
Figure 2
Carbapenem consumption and MDR-Acinetobacter baumannii isolations.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Berezin BE, Towner KJ. Acinetobacter spp as nosocomial pathogens. Microbiological, clinical and epidemiological features. Clin Microbiol Rev. 1996;13:148–165. - PMC - PubMed
    1. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;13:3471–3484. doi: 10.1128/AAC.01464-06. - DOI - PMC - PubMed
    1. Jaggi N, Sissodia P, Sharma L. Control of multidrug resistant bacteria in a tertiary care hospital in India. Antimicrob Resist Infect Control. 2012;13(1):23. - PMC - PubMed
    1. Paterson DL. Serious infections in the intensive care unit: Pseudomonas aeruginosa and Acinetobacterbaumannii. Clin Infect Dis. 2006;13(2):S41–S42.
    1. Peleg ΑΥ, Seifert Η, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;13:538–582. doi: 10.1128/CMR.00058-07. - DOI - PMC - PubMed

MeSH terms